Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00098124
Other study ID # MLN-MD-02
Secondary ID
Status Completed
Phase Phase 3
First received December 3, 2004
Last updated December 18, 2007
Start date November 2004
Est. completion date December 2006

Study information

Verified date December 2007
Source Forest Laboratories
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.


Recruitment information / eligibility

Status Completed
Enrollment 1200
Est. completion date December 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria

Exclusion Criteria:

- Psychiatric illness

- Depression

- Suicidal risk

- Substance abuse

- Pulmonary dysfunction

- Renal impairment

- Active cardiac disease

- Liver disease

- Autoimmune disease

- Cancer

- Sleep apnea

- Inflammatory bowel disease

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
milnacipran hydrochloride


Locations

Country Name City State
United States Forest Investigative Site Austin Texas
United States Forest Investigative Site Baltimore Maryland
United States Forest Investigative Site Bellingham Washington
United States Forest Investigative Site Bend Oregon
United States Forest Investigative Site Beverly Hills California
United States Forest Investigative Site Birmingham Alabama
United States Forest Investigative Site Bismarck North Dakota
United States Forest Investigative Site Bristol Tennessee
United States Forest Investigative Site Charlotte North Carolina
United States Forest Investigative Site Chattanooga Tennessee
United States Forest Investigative Site Cherry Hill New Jersey
United States Forest Investigative Site Chicago Illinois
United States Forest Investigative Site Clearwater Florida
United States Forest Investigative Site Clementon New Jersey
United States Forest Investigative Site Colorado Springs Colorado
United States Forest Investigative Site Colorado Springs Colorado
United States Forest Investigative Site Columbia Maryland
United States Forest Investigative Site Danbury Connecticut
United States Forest Investigative Site Decatur Georgia
United States Forest Investigative Site Deland Florida
United States Forest Investigative Site Delray Beach Florida
United States Forest Investigative Site Duncanville Pennsylvania
United States Forest Investigative Site East Syracuse New York
United States Forest Investigative Site Eugene Oregon
United States Forest Investigative Site Evansville Indiana
United States Forest Investigative Site Everett Washington
United States Forest Investigative Site Fayetteville North Carolina
United States Forest Investigative Site Flowood Mississippi
United States Forest Investigative Site Frederick Maryland
United States Forest Investigative Site Great Neck New York
United States Forest Investigative Site Hickory North Carolina
United States Forest Investigative Site Honolulu Hawaii
United States Forest Investigative Site Jacksonville Florida
United States Forest Investigative Site Kalamazoo Michigan
United States Forest Investigative Site Lafayette Indiana
United States Forest Investigative Site Lexington Kentucky
United States Forest Investigative Site Libertyville Illinois
United States Forest Investigative Site Marion Ohio
United States Forest Investigative Site Medford Oregon
United States Forest Investigative Site Memphis Tennessee
United States Forest Investigative Site Meridian Idaho
United States Forest Investigative Site Missoula Montana
United States Forest Investigative Site Mobile Alabama
United States Forest Investigative Site Montgomery Alabama
United States Forest Investigative Site Newton Massachusetts
United States Forest Investigative Site North Dartmouth Massachusetts
United States Forest Investigative Site Ocala Florida
United States Forest Investigative Site Oklahoma City Oklahoma
United States Forest Investigative Site Orangeburg South Carolina
United States Forest Investigative Site Ormond Beach Florida
United States Forest Investigative Site Palm Harbor Florida
United States Forest Investigative Site Pembroke Pines Florida
United States Forest Investigative Site Peoria Arizona
United States Forest Investigative Site Peoria Illinois
United States Forest Investigative Site Port Orange Florida
United States Forest Investigative Site Portland Oregon
United States Forest Investigative Site Racine Wisconsin
United States Forest Investigative Site Raleigh North Carolina
United States Forest Investigative Site Raleigh North Carolina
United States Forest Investigative Site Richmond Virginia
United States Forest Investigative Site Rochester New York
United States Forest Investigative Site Sacramento California
United States Forest Investigative Site San Antonio Texas
United States Forest Investigative Site San Diego California
United States Forest Investigative Site San Diego California
United States Forest Investigative Site Santa Ana California
United States Forest Investigative Site Santa Fe New Mexico
United States Forest Investigative Site Seattle Washington
United States Forest Investigative Site Spring Valley California
United States Forest Investigative Site St. Louis Missouri
United States Forest Investigative Site Stamford Connecticut
United States Forest Investigative Site Sugarland Texas
United States Forest Investigative Site Tamarac Florida
United States Forest Investigative Site Torrance California
United States Forest Investigative Site Trumball Connecticut
United States Forest Investigative Site Virginia Beach Virginia
United States Forest Investigative Site Warwick Rhode Island
United States Forest Investigative Site Wenatchee Washington
United States Forest Investigative Site Wichita Kansas
United States Forest Investigative Site Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Forest Laboratories

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Composite responder analysis based on pain and patient global status, with or without physical function.
Secondary Quality of Life
Secondary Health Assessment Questionnaire (HAQ) Disability Index
Secondary Fatigue, sleep and cognitive assessments
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05659862 - Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT03042728 - Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program N/A
Recruiting NCT06097091 - Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia N/A
Recruiting NCT04554784 - Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia N/A
Completed NCT03300635 - Metabolism, Muscle Function and Psychological Factors in Fibromyalgia N/A
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT03166995 - Postural Exercises in Women With Fibromyalgia N/A
Completed NCT03227952 - Sensory Stimulation in Fibromyalgia N/A
Recruiting NCT06237595 - Vagus Nerve Stimulation in Fibromyalgia N/A
Completed NCT01888640 - Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST) N/A
Completed NCT03641495 - Pain Education and Therapeutic Exercise for Fibromyalgia N/A
Recruiting NCT05581628 - FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
Active, not recruiting NCT05128162 - Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Phase 2
Completed NCT04674878 - Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia N/A
Active, not recruiting NCT04084795 - Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia N/A
Completed NCT03129906 - Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients N/A
Completed NCT05058911 - Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia N/A
Recruiting NCT04571853 - New Educational Tool for FM N/A
Recruiting NCT04571528 - Effectiveness of VIRTUAL FIBROWALK STUDY N/A